Target intelligence / Profile preview

Listonella anguillarum serotype O1 (L. anguillarum O1)

Target
L. anguillarum O1
Molecular classification
Bacterial pathogen, Gram-negative bacterium
01

Overview

Listonella anguillarum serotype O1, more commonly known as Vibrio anguillarum, is a Gram-negative, halophilic bacterium that acts as a primary pathogen in marine and estuarine aquaculture. It is the causative agent of vibriosis, a severe hemorrhagic septicemia that affects a wide range of fish species, including salmonids, eels, and sea bream (Frans et al., 2011). The virulence of this serotype is largely mediated by its sophisticated iron-acquisition systems, such as the pJM1 plasmid-encoded anguibactin, and its ability to adhere to and colonize host mucosal surfaces (Actis et al., 2011). While not a single molecular target like a receptor or enzyme, L. anguillarum O1 is the focus of therapeutic strategies involving broad-spectrum antibiotics and inactivated whole-cell vaccines (Toranzo et al., 2005). These interventions aim to either directly inhibit bacterial growth or prime the host's immune system to recognize and neutralize the pathogen's surface lipopolysaccharides and proteins. Effective management of this pathogen is essential for reducing mortality rates and economic losses in the global fishing and aquaculture sectors.

Other names
Vibrio anguillarum serotype O1V. anguillarum O1Vibrio anguillarumListonella anguillarum
02

Mechanism of action

Antibiotics like florfenicol inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, while vaccines (bacterins) provide protective immunity by exposing the host to inactivated bacterial cells, primarily targeting the O-antigen of the lipopolysaccharide.

03

Biological functions

PathogenesisIron acquisitionBiofilm formationMotilityAdhesion
04

Disease associations

VibriosisHemorrhagic septicemiaInfection
05

Safety considerations

Antimicrobial resistance developmentEnvironmental toxicity of aquaculture drugsVaccine-induced side effects in fish
06

Interacting drugs

Oxytetracycline

4 more in the full profile.

07

Biomarkers

O-antigenAnguibactinpJM1 plasmid DNA

Beyond the preview

Go deeper on Listonella anguillarum serotype O1 (L. anguillarum O1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Listonella anguillarum serotype O1 (L. anguillarum O1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call